These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38224338)

  • 1. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
    Shahim B; Xu H; Haugaa K; Zetterberg H; Jurga J; Religa D; Eriksdotter M
    Eur Heart J Cardiovasc Pharmacother; 2024 Feb; 10(2):128-136. PubMed ID: 38224338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease.
    Nordström P; Religa D; Wimo A; Winblad B; Eriksdotter M
    Eur Heart J; 2013 Sep; 34(33):2585-91. PubMed ID: 23735859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).
    Fereshtehnejad SM; Johnell K; Eriksdotter M
    Drugs Aging; 2014 Mar; 31(3):215-24. PubMed ID: 24497071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry.
    Secnik J; Schwertner E; Alvarsson M; Hammar N; Fastbom J; Winblad B; Garcia-Ptacek S; Religa D; Eriksdotter M
    BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Xu H; Garcia-Ptacek S; Jönsson L; Wimo A; Nordström P; Eriksdotter M
    Neurology; 2021 Apr; 96(17):e2220-e2230. PubMed ID: 33741639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes.
    Charbonneau C; Massoud F; Dorais M; LeLorier J
    Curr Med Res Opin; 2008 Dec; 24(12):3287-94. PubMed ID: 19032117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.
    Pyun JM; Ryoo N; Park YH; Kim S
    Alzheimers Res Ther; 2021 Jan; 13(1):10. PubMed ID: 33402198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
    Haywood WM; Mukaetova-Ladinska EB
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer's dementia.
    Xu H; Garcia-Ptacek S; Bruchfeld A; Fu EL; Shori TD; Lindholm B; Eriksdotter M; Carrero JJ
    Kidney Int; 2023 Jan; 103(1):166-176. PubMed ID: 36341731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study.
    Masurkar PP; Chatterjee S; Sherer JT; Chen H; Johnson ML; Aparasu RR
    Drugs Aging; 2022 Jun; 39(6):453-465. PubMed ID: 35666463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation.
    Fisher A; Carney G; Bassett K; Chappell NL
    Value Health; 2016; 19(5):688-96. PubMed ID: 27565287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase Inhibitors Response Might Be Related to Right Hippocampal Functional Connectivity in Mild Alzheimer's Disease.
    Rizzi L; Cardoso Magalhães TN; Lecce N; Dos Santos Moraes A; Fernandes Casseb R; Vieira Ligo Teixeira C; Machado de Campos B; Junqueira Ribeiro de Rezende T; Leme Talib L; Forlenza OV; Cendes F; Balthazar MLF
    Brain Connect; 2023 Jun; 13(5):269-274. PubMed ID: 35994390
    [No Abstract]   [Full Text] [Related]  

  • 13. To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease.
    Diniz BS; Pinto JA; Gonzaga ML; Guimarães FM; Gattaz WF; Forlenza OV
    Eur Arch Psychiatry Clin Neurosci; 2009 Jun; 259(4):248-56. PubMed ID: 19224111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
    Mucha L; Shaohung S; Cuffel B; McRae T; Mark TL; Del Valle M
    J Manag Care Pharm; 2008 Jun; 14(5):451-61. PubMed ID: 18597574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study.
    Hsieh MJ; Chen DY; Lee CH; Wu CL; Chen YJ; Huang YT; Chang SH
    Front Cardiovasc Med; 2022; 9():831730. PubMed ID: 35369359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative.
    Schneider LS; Insel PS; Weiner MW;
    Arch Neurol; 2011 Jan; 68(1):58-66. PubMed ID: 21220675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors for Alzheimer disease: do they provide more than symptomatic benefits?
    Suh GH; Ryu SH; Lee DW; Han C; Ju YS; Kee BS; Lee JN; Bae JN; Choi JH; Kim DJ; Lee NJ; Lee JY; Go HJ; Yi JS; Cho SJ; Jeon YW
    Am J Geriatr Psychiatry; 2011 Mar; 19(3):266-73. PubMed ID: 20808128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review.
    Grimmer T; Kurz A
    Drugs Aging; 2006; 23(12):957-67. PubMed ID: 17154660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.